Novel synthetic curcumin analogs as potent antiangiogenic agents in colorectal cancer

Cancer statistics, 2015

(2015) Rebecca L. Siegel et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Antiangiogenic effects of a novel synthetic curcumin analogue in pancreatic cancer

(2015) Ganji Purnachandra Nagaraju et al.   CANCER LETTERS

Broad targeting of angiogenesis for cancer prevention and therapy

(2015) Zongwei Wang et al.   SEMINARS IN CANCER BIOLOGY

HSP90 inhibition downregulates thymidylate synthase and sensitizes colorectal cancer cell lines to the effect of 5FU-based chemotherapy

(2015) Ganji Purnachandra Nagaraju et al.   Oncotarget

The Neurotensin–HIF-1α–VEGFα Axis Orchestrates Hypoxia, Colonic Inflammation, and Intestinal Angiogenesis

(2014) Kyriaki Bakirtzi et al.   AMERICAN JOURNAL OF PATHOLOGY

Synthetic Curcumin Analog UBS109 Inhibits the Growth of Head and Neck Squamous Cell Carcinoma Xenografts

(2014) Shijun Zhu et al.   CURRENT CANCER DRUG TARGETS

Erratum to: Antiangiogenic effects of ganetespib in colorectal cancer mediated through inhibition of HIF-1α and STAT-3

(2013) Ganji Purnachandra Nagaraju et al.   ANGIOGENESIS

Novel synthetic curcumin analogues EF31 and UBS109 are potent DNA hypomethylating agents in pancreatic cancer

(2013) Ganji Purnachandra Nagaraju et al.   CANCER LETTERS

Curcumin Enhances the Effect of Chemotherapy against Colorectal Cancer Cells by Inhibition of NF-κB and Src Protein Kinase Signaling Pathways

(2013) Mehdi Shakibaei et al.   PLoS One

Synthetic curcumin analog EF31 inhibits the growth of head and neck squamous cell carcinoma xenografts

(2012) Shijun Zhu et al.   Integrative Biology

The impact of curcumin on breast cancer

(2012) Ganji Purnachandra Nagaraju et al.   Integrative Biology

Antiangiogenic agents increase breast cancer stem cells via the generation of tumor hypoxia

(2012) S. J. Conley et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Antiangiogenic Drugs Increase Xenograft Aggressiveness

(2012)   Cancer Discovery

Inhibition of the NF-κB signaling pathway by the curcumin analog, 3,5-Bis(2-pyridinylmethylidene)-4-piperidone (EF31): Anti-inflammatory and anti-cancer properties

(2011) Anlys Olivera et al.   INTERNATIONAL IMMUNOPHARMACOLOGY

Curcumin in Cancer Chemoprevention: Molecular Targets, Pharmacokinetics, Bioavailability, and Clinical Trials

(2010) Adeeb Shehzad et al.   ARCHIV DER PHARMAZIE

Curcumin as a therapeutic agent: the evidence from in vitro, animal and human studies

(2010) Jenny Epstein et al.   BRITISH JOURNAL OF NUTRITION

A Critical Role of Activin A in Maturation of Mouse Peritoneal Macrophages in vitro and in vivo

(2010) Yinan Wang et al.   Cellular & Molecular Immunology

Targeting NF-κB for colorectal cancer

(2010) Kei Sakamoto et al.   EXPERT OPINION ON THERAPEUTIC TARGETS

Constitutive NF- B Activation in Colorectal Carcinoma Plays a Key Role in Angiogenesis, Promoting Tumor Growth

(2009) K. Sakamoto et al.   CLINICAL CANCER RESEARCH

The role of COX-2 in intestinal inflammation and colorectal cancer

(2009) D Wang et al.   ONCOGENE

Cyclooxygenase-2 Expression Is an Independent Predictor of Poor Prognosis in Colon Cancer

(2008) S. Ogino et al.   CLINICAL CANCER RESEARCH

Role of HIF-1 and NF-κB Transcription Factors in the Modulation of Transferrin Receptor by Inflammatory and Anti-inflammatory Signals

(2008) Lorenza Tacchini et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

IKK/NF-κB signaling in intestinal epithelial cells controls immune homeostasis in the gut

(2008) M Pasparakis   Mucosal Immunology